EMBARGOED FOR RELEASE: 3 P.M. (CT), WEDNESDAY, NOVEMBER 19, 2014
Media Advisory: To contact author Kristy L. Kummerow, M.D., call Craig Boerner at 615-322-4747 or email email@example.com. To contact corresponding commentary author Michael E. Zenilman, M.D., call Vanessa Wasta at 410-614-2916 or email firstname.lastname@example.org. A podcast will be available when the embargo lifts on the JAMA Surgery website at http://bit.ly/1dDjZYQ
To place an electronic embedded link to this study in your story: Links will be live at the embargo time: http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/jamasurg.2014.2895 and http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/jamasurg.2014.2902.
Higher proportions of women eligible for breast conservation surgery (BCS) are undergoing mastectomy, breast reconstruction and bilateral mastectomy (surgical removal of both breasts), with the steepest increases seen in women with lymph node-negative and in situ (contained) disease, according to a report published online by JAMA Surgery.
BCS has been a standard of excellence in breast cancer care and its use for management of early-stage breast cancer had increased steadily since the 1990s. However there is evidence that that trend may be reversing.
Kristy L. Kummerow, M.D., of Vanderbilt University Medical Center, Nashville, Tenn., and her co-authors examined trends nationwide in mastectomy patients eligible for BCS. The authors used the National Cancer Data Base to study more than 1.2 million women treated at centers accredited by the American Cancer Society and the American College of Surgeons Commission on Cancer from January 1998 through December 2011.
The study showed that 35.5 percent of the study group underwent mastectomy. The proportion of BCS-eligible women with early-stage breast cancer who underwent mastectomy increased from 34.3 percent in 1998 to 37.8 percent in 2011. Younger women were more likely to undergo mastectomy regardless of tumor size, while in older women mastectomy was associated with having a tumor greater than 2 centimeters. In women undergoing mastectomy, rates of breast reconstruction increased from 11.6 percent in 1998 to 36.4 percent in 2011. Rates of bilateral mastectomy for unilateral (in one breast) disease increased from 1.9 percent in 1998 to 11.2 percent in 2011.
The authors note that the observed increase in mastectomy rates was largely due to a rise in bilateral mastectomy for unilateral, early-stage disease from 5.4 percent of mastectomies in 1998 to 29.7percent in 2011, with an increase at the same time in reconstructive procedures in this group from 36.9 percent to 57.2 percent.
“Our finding of still-increasing rates of mastectomy, breast reconstruction and bilateral mastectomy in women with early-stage breast cancer using 14 years of data from the NCDB has implications for physician and patient decision making as well as quality measurement. Further research is needed to understand patient, provider, policy and social factors associated with these trends,” the authors conclude.
(JAMA Surgery. Published online November 19, 2014. doi:10.1001/jamasurg.2014.2895. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor’s Note: This material is based on work supported by the Office of Academic Affiliations, Department of Veterans Affairs, Veterans Affairs National Quality Scholars Program and with use of facilities at Veterans Affairs Tennessee Valley Healthcare System, Nashville. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: The Swinging Pendulum In a related commentary, Bonnie Sun, M.D., and Michael E. Zenilman, M.D., of Johns Hopkins Medicine, Baltimore, write: “Existing guidelines are in place to ensure that patients are offered the appropriate options. The article by Kummerow et al should at least serve as a wake-up call that as we fulfill that responsibility, and use every modality of care to give patients the best quality of life and survival advantage, the guidelines may need to change again.”
(JAMA Surgery. Published online November 19, 2014. doi:10.1001/jamasurg.2014.2902. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor’s Note: An author made a conflict of interest disclosure. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email email@example.com.